Elanco Animal Health (ELAN) Leases (2018 - 2025)
Elanco Animal Health (ELAN) reported Leases of $226.0 million for Q4 2025, up 85.25% on a YoY basis from $122.0 million in Q4 2024, and up 85.25% sequentially from $122.0 million in Q4 2024.
Elanco Animal Health (ELAN) Leases (2018 - 2025) Analysis & Trends
Elanco Animal Health (ELAN) has 8 years of Leases data on file, last reported at $226.0 million in Q4 2025.
- For the quarter ending Q4 2025, Leases rose 85.25% year-over-year to $226.0 million; the trailing twelve-month figure through Dec 2025 stood at $226.0 million (up 85.25% YoY), and the FY2025 full-year result was $226.0 million, up 85.25% from the prior year.
- Leases advanced to $226.0 million in Q4 2025, from $122.0 million in the prior quarter.
- In the past five years, Leases ranged from a high of $226.0 million in Q4 2025 to a low of $122.0 million in Q4 2024.
- A 5-year average of $158.0 million and a median of $141.0 million in 2022 frame the typical range for Leases.
- Across the five-year window, Leases declined 13.9% in 2021 and jumped 85.25% in 2025, its largest moves.
- Tracing ELAN's Leases over 5 years: stood at $161.0 million in 2021, then decreased by 12.42% to $141.0 million in 2022, then declined by 0.71% to $140.0 million in 2023, then dropped by 12.86% to $122.0 million in 2024, then surged by 85.25% to $226.0 million in 2025.
- Business Quant data shows ELAN's Leases at $226.0 million in Q4 2025, $122.0 million in Q4 2024, and $140.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 335.00 Mn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | 282.00 Mn |
| 4 | Takeda Pharmaceutical | 27.62 Bn | 23.56 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | 1.06 Mn |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 253.00 Mn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 447.10 Mn |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 84.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 226.00 Mn |
| Dec 31, 2024 | 122.00 Mn |
| Dec 31, 2023 | 140.00 Mn |
| Dec 31, 2022 | 141.00 Mn |
| Dec 31, 2021 | 161.00 Mn |
| Dec 31, 2020 | 187.00 Mn |
| Dec 31, 2019 | 85.00 Mn |
| Sep 30, 2019 | 81.70 Mn |
| Jun 30, 2019 | 81.30 Mn |
| Mar 31, 2019 | 80.70 Mn |
| Dec 31, 2018 | 84.90 Mn |